GlassScriptPhysician profile
Rachel L Spieldoch
NPI 1730144858
$9,408.49
in general payments reported to CMS, 2019-2025
45 companies · $944 in 2025
The $944 reported for 2025 was more than what 83% of Gynecology providers received nationally (typical 2025 total: $162).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $616 · 2020: $724 · 2021: $691 · 2022: $2,940 · 2023: $2,860 · 2024: $634 · 2025: $944.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,064 · Travel and Lodging: $364 · Gift: $10.49.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,063.57 |
| Travel and Lodging | $364.44 |
| Gift | $10.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hologic Sales and Service, LLC | $2,431.68 | 2020-2025 | Acessa Provu System, Novasure, Myosure Tissue Removal Device |
| Intuitive Surgical, INC. | $1,290.25 | 2020-2024 | Da Vinci Surgical System |
| Momentis Surgical INC. | $855.00 | 2022 | |
| Gynesonics, INC. | $849.17 | 2022-2025 | Sonata Sonography-Guided Transcervical Fibroid Ablation System, Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Abbvie INC. | $511.67 | 2019-2025 | Orilissa, Lo Loestrin Fe, Liletta |
| Myovant Sciences INC. | $305.83 | 2021-2022 | |
| Sumitomo Pharma America, INC. | $297.93 | 2023-2025 | Myfembree |
| Minerva Surgical, INC | $268.86 | 2019-2024 | |
| Therapeuticsmd, INC. | $253.27 | 2019-2022 | |
| Femselect INC. | $252.55 | 2025 | Enplace |
| Caldera Medical, INC | $206.39 | 2023-2024 | Desara |
| Mayne Pharma Commercial LLC | $203.17 | 2021-2025 | |
| Channel Medsystems, INC. | $137.16 | 2022-2023 | |
| Astellas Pharma US INC | $134.57 | 2023-2025 | Veozah |
| Alexion Pharmaceuticals, INC. | $106.32 | 2019 |
Show all 45 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Baxter Healthcare | $105.37 | 2019-2025 | Perclot |
| Exeltis, USA INC. | $100.10 | 2019-2025 | Slynd |
| Organon LLC | $90.96 | 2021-2024 | |
| Merck Sharp & Dohme LLC | $81.89 | 2019-2021 | |
| Shield Therapeutics INC | $76.10 | 2022-2025 | |
| Novo Nordisk INC | $71.27 | 2019-2024 | Wegovy |
| Coopersurgical, INC. | $68.07 | 2020-2023 | Endosee |
| Kowa Pharmaceuticals America, INC. | $66.76 | 2023 | Seglentis |
| Medtronic, INC. | $66.39 | 2022 | |
| Avion Pharmaceuticals | $60.82 | 2019-2023 | Balcoltra |
| Axonics, INC. | $54.44 | 2022-2023 | Axonics |
| Evofem Biosciences, INC. | $47.18 | 2021 | |
| Aspira Women'S Health INC | $43.83 | 2023-2024 | Ova1 |
| Lupin INC. | $40.98 | 2019-2020 | |
| Boston Scientific Corporation | $40.36 | 2023-2024 | Solyx Sis System, Obtryx System - Curved |
| Millicent US INC | $39.48 | 2020-2024 | Intrarosa |
| Amgen INC. | $28.71 | 2019 | |
| Coloplast Corp | $24.11 | 2025 | |
| Applied Medical Resources Corporation | $24.00 | 2023 | |
| Bayer Healthcare Pharmaceuticals INC. | $19.87 | 2022 | |
| Daiichi Sankyo INC. | $18.92 | 2020 | |
| Scynexis, INC. | $18.12 | 2022 | |
| Intra-Sana Laboratories | $17.89 | 2024 | Reltone 200 Mg, Glycate, Reltone 400 Mg |
| Mimedx Group, INC. | $17.40 | 2024 | |
| Hologic INC | $16.87 | 2021 | |
| Agile Therapeutics, INC. | $14.30 | 2022 | |
| Dysis Medical, INC. | $13.32 | 2019 | |
| Allergan, INC. | $13.27 | 2019 | |
| Trevena, INC. | $12.34 | 2021 | |
| Mylan Pharmaceuticals INC. | $11.55 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rachel Spieldoch listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.